Literature DB >> 20828613

Matrix remodeling as stem cell recruitment event: a novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix.

Joshua Mauney1, Bjorn R Olsen, Vladimir Volloch.   

Abstract

The goal of the present study was to devise an in vitro model suitable for investigations of the homing of mesenchymal stem cells to sites of injury. Such a model was designed on the basis of a "transwell" assay, with an insert seeded with human bone marrow stromal cells and a well with a desired cell type. To mimic physiological environment and to simulate "injury", cells in a well were maintained not only on tissue culture plastic but also on collagens I and IV, major matrix components in musculoskeletal and adipose tissues respectively, and subjected to a severe thermal stress. The results obtained showed a massive translocation of bone marrow stromal cells through the inserts' membrane toward the "injury" site. Unexpectedly, it emerged that collagen matrix is essential in producing such a migration. The results obtained suggest that upon injury cells secrete a substance which interacts with collagen matrix to produce a homing agent. The substance in question appears to be a protease and its interaction with the collagen matrix appears to be a digestion of the latter into fragments shown to be chemotactic. Both AEBSF, an inhibitor of serine proteases, and leupeptin, an inhibitor of cysteine proteases as well as of trypsin-like serine proteases, but not the broad spectrum MMP inhibitor marimastat, significantly inhibit the observed homing effect and this inhibition is not due to cytotoxicity. Moreover, immunoprecipitation of HTRA1, a trypsin-like serine protease known to be secreted by cells differentiating into all three major mesenchymal lineages and by stressed cells in general and shown to degrade a number of matrix proteins including collagen, significantly diminished the homing effect. The data suggest that this protease is a major contributor to the observed chemotaxis of bone marrow stromal cells. The present study indicates that collagen fragments can mediate the migration of bone marrow stromal cells. The results also suggest that, at least in musculoskeletal and in adipose tissues, matrix remodeling occurrences, usually closely associated with tissue remodeling, should also be regarded as potential stem cells recruitment events.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20828613      PMCID: PMC6817338          DOI: 10.1016/j.matbio.2010.08.008

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  59 in total

Review 1.  Socializing with the neighbors: stem cells and their niche.

Authors:  Elaine Fuchs; Tudorita Tumbar; Geraldine Guasch
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

2.  Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.

Authors:  Joshua R Mauney; Vladimir Volloch; David L Kaplan
Journal:  Biomaterials       Date:  2005-11       Impact factor: 12.479

3.  Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity.

Authors:  Tatiana Tondreau; Nathalie Meuleman; Alain Delforge; Marielle Dejeneffe; Rita Leroy; Martine Massy; Christine Mortier; Dominique Bron; Laurence Lagneaux
Journal:  Stem Cells       Date:  2005-06-13       Impact factor: 6.277

4.  The role of human HtrA1 in arthritic disease.

Authors:  Sandra Grau; Peter J Richards; Briedgeen Kerr; Clare Hughes; Bruce Caterson; Anwen S Williams; Uwe Junker; Simon A Jones; Tim Clausen; Michael Ehrmann
Journal:  J Biol Chem       Date:  2005-12-22       Impact factor: 5.157

Review 5.  Molecular mechanisms of bone resorption by the osteoclast.

Authors:  R Baron
Journal:  Anat Rec       Date:  1989-06

6.  Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis.

Authors:  Akiho Tsuchiya; Masato Yano; Jiraporn Tocharus; Hisae Kojima; Manabu Fukumoto; Masashi Kawaichi; Chio Oka
Journal:  Bone       Date:  2005-09       Impact factor: 4.398

Review 7.  Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.

Authors:  G Vaes
Journal:  Clin Orthop Relat Res       Date:  1988-06       Impact factor: 4.176

8.  Osteogenesis by human osteoblastic cells in diffusion chamber in vivo.

Authors:  Y Gotoh; K Fujisawa; K Satomura; M Nagayama
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

9.  The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells.

Authors:  Alfonso Baldi; Antonio De Luca; Monica Morini; Tullio Battista; Armando Felsani; Feliciano Baldi; Caterina Catricalà; Ada Amantea; Douglas M Noonan; Adriana Albini; Pier Giorgio Natali; Daniela Lombardi; Marco G Paggi
Journal:  Oncogene       Date:  2002-09-26       Impact factor: 9.867

10.  Progression of human bone marrow stromal cells into both osteogenic and adipogenic lineages is differentially regulated by structural conformation of collagen I matrix via distinct signaling pathways.

Authors:  Josh Mauney; Vladimir Volloch
Journal:  Matrix Biol       Date:  2009-04-16       Impact factor: 11.583

View more
  17 in total

1.  Subventricular zone microglia transcriptional networks.

Authors:  Sarah C Starossom; Jaime Imitola; Yue Wang; Li Cao; Samia J Khoury
Journal:  Brain Behav Immun       Date:  2010-11-11       Impact factor: 7.217

Review 2.  Systems biology approach to developing S(2)RM-based "systems therapeutics" and naturally induced pluripotent stem cells.

Authors:  Greg Maguire; Peter Friedman
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

3.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

4.  Stemming the Degeneration: IVD Stem Cells and Stem Cell Regenerative Therapy for Degenerative Disc Disease.

Authors:  V Sivakamasundari; Thomas Lufkin
Journal:  Adv Stem Cells       Date:  2013

Review 5.  Extracellular matrix bioscaffolds in tissue remodeling and morphogenesis.

Authors:  Ilea T Swinehart; Stephen F Badylak
Journal:  Dev Dyn       Date:  2016-01-13       Impact factor: 3.780

6.  Why cellular stress suppresses adipogenesis in skeletal tissue, but is ineffective in adipose tissue: control of mesenchymal cell differentiation via integrin binding sites in extracellular matrices.

Authors:  Vladimir Volloch; Bjorn R Olsen
Journal:  Matrix Biol       Date:  2013-06-18       Impact factor: 11.583

7.  Self-assembling peptide nanofibers coupled with neuropeptide substance P for bone tissue engineering.

Authors:  Su Hee Kim; Woojune Hur; Ji Eun Kim; Hye Jeong Min; Sukwha Kim; Hye Sook Min; Byeung Kyu Kim; Soo Hyun Kim; Tae Hyun Choi; Youngmee Jung
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

8.  Radiation-induced bystander effects in cultured human stem cells.

Authors:  Mykyta V Sokolov; Ronald D Neumann
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

9.  Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1.

Authors:  Sarah Melissa P Jacobo; Margaret M Deangelis; Ivana K Kim; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

10.  Neurorestorative effect of urinary bladder matrix-mediated neural stem cell transplantation following traumatic brain injury in rats.

Authors:  J Y Wang; Akf Liou; Z H Ren; L Zhang; B N Brown; X T Cui; S F Badylak; Y N Cai; Y Q Guan; Rehana K Leak; J Chen; X Ji; L Chen
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.